- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00818116
Visual Function Evaluation of Bilateral AcrySof ReSTOR Aspheric IOL
June 30, 2010 updated by: Alcon Research
Visual Function After Implantation of Bilateral AcrySof ReSTOR Aspheric Intraocular Lens (IOL): Postmarket Evaluation
The objective of this study is to evaluate postoperative visual function in patients implanted bilaterally with the ReSTOR Aspheric Intraocular Lens (IOL).
Study Overview
Study Type
Interventional
Enrollment (Actual)
34
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Fort Worth, Texas, United States, 76134
- Alcon Call Center for Trial Locations
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Bilateral cataract patients who require natural crystalline lens removal and bilateral Intraocular Lens (IOL) implantation.
- 50~75 years of age
- <1 Diopter of astigmatism preoperatively (before surgery) as measured by Keratometry readings.
Exclusion Criteria:
- Patients with pre-existing conditions that could skew the results.
- Any of conditions before and during surgery specified in the product information.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: ReSTOR Aspheric IOL
Bilateral implantation with the AcrySof ReSTOR Aspheric Intraocular Lens (IOL)
|
Bilateral implantation with the AcrySof ReSTOR Aspheric Intraocular Lens (IOL) for the replacement of cataract in the natural lens of the eye.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Uncorrected and Best Corrected Visual Acuities (Near and Distance)
Time Frame: 6 Months Following Cataract Surgery
|
Measurement of uncorrected (without spectacles or other visual corrective devices) and best-corrected (with spectacles or other visual corrective devices)visual acuity at both near and distance.
Visual Acuity (VA) is measured in logMAR.
LogMAR is the "logarithm of the minimum angle of resolution".
A lower logMAR value indicates better visual acuity.
|
6 Months Following Cataract Surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2008
Primary Completion (Actual)
July 1, 2009
Study Registration Dates
First Submitted
January 6, 2009
First Submitted That Met QC Criteria
January 6, 2009
First Posted (Estimate)
January 7, 2009
Study Record Updates
Last Update Posted (Estimate)
July 30, 2010
Last Update Submitted That Met QC Criteria
June 30, 2010
Last Verified
June 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CH-08-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataracts
-
Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co...Enrolling by invitation
-
Johnson & Johnson Surgical Vision, Inc.TerminatedCataractsUnited States
-
Johnson & Johnson Surgical Vision, Inc.Completed
-
Johnson & Johnson Surgical Vision, Inc.Completed
-
Johnson & Johnson Surgical Vision, Inc.Completed
-
Johnson & Johnson Surgical Vision, Inc.Completed
-
Medical University of South CarolinaTerminated
-
Alcon ResearchCompleted
-
Alcon ResearchCompleted
Clinical Trials on AcrySof ReSTOR Aspheric IOL
-
Alcon ResearchCompleted
-
Alcon ResearchCompleted
-
Alcon ResearchTerminated
-
Medical University of South CarolinaCompleted
-
Alcon ResearchCompleted
-
Alcon ResearchWithdrawnVisual OutcomesUnited States
-
Medical University of South CarolinaCompletedCataract Extraction | Refractive SurgeryUnited States
-
Alcon ResearchCompleted
-
Alcon ResearchCompleted
-
Medical University of South CarolinaWithdrawnCataract | VisionUnited States